← Back to headlines
Eli Lilly shares fall after serious Foundayo adverse event report
Shares of pharmaceutical company Eli Lilly are under pressure following a report of a serious adverse event related to its drug, Foundayo.
4 May, 14:32 — 4 May, 14:32
Sources
Showing 1 of 1 sources
